The landscape of diabetes care is evolving with the arrival of skin-applied GLP-1 therapy. These convenient delivery systems offer a possibly more comfortable alternative to needle administrations for individuals living with type 2 diabetes . They deliver a GLP-1 agonist directly through the derm